Healthy (asymptomatic) subjects (A) | ||||||
---|---|---|---|---|---|---|
AAT-variant | N | AAT (mg/ml) | N | ACT (mg/ml) | N | SLPI (ng/ml) |
Mean* ± SD | Mean* ± SD | Mean* ± SD | ||||
ZZ | 10 | 0.20 ± 0.03 | 10 | 0.40 ± 0.20 | 9 | 44.0 ± 15 |
MM | 20 | 1.37 ± 0.20 | 15 | 0.37 ± 0.15 | 13 | 38.2 ± 9.9 |
COPD subjects (B) | ||||||
AAT-variant | N | AAT (mg/ml) | N | ACT (mg/ml) | N | SLPI (ng/ml) |
Mean* ± SD | Mean* ± SD | Mean* ± SD | ||||
ZZ | 10 | 0.32 ± 0.17 | 10 | 0.42 ± 0.12 | 10 | 48.5 ± 8.4 |
MM | 10 | 1.73 ± 0.22 | 9 | 0.62 ± 0.21 | 9 | 51.1 ± 6.1 |